The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer
Abstract Non-small cell lung cancer (NSCLC) remains a dire disease being the first cause of cancer death among both genders. Early-stage NSCLC often has better treatment outcomes despite it being a highly heterogeneous disease. So far, the neo-adjuvant chemotherapy strategies have led to a small ben...
| 出版年: | Discover Oncology |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Springer
2025-01-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1007/s12672-025-01826-7 |
